Lung inflammation may speed heart aging, study investigates
NCT ID NCT02804971
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study looks at whether chronic lung inflammation from bronchiectasis raises the risk of heart disease and accelerates aging. Researchers will measure heart function, artery stiffness, bone density, muscle mass, and blood markers in 110 adults aged 40 to 80 with confirmed bronchiectasis. The goal is to understand how often these problems occur and whether they relate to the severity of lung disease.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If links are found, it could point toward ways to monitor and reduce heart disease risk in people with bronchiectasis.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. The findings may not apply to all patients with bronchiectasis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
110 people
The number who actually took part.
- Started
-
Oct 2016
- Finished
-
Dec 2021
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with a diagnosis of bronchiectasis based on imaging in a recent (less than 2 years) CT-scan.
- Ages
-
40 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 40 ≤ Age ≤ 80 years * Formal diagnosis of bronchiectasis by imaging (CT-scan) * For women, pregnancy test negative * Affiliation to a social Security * written inform consent Exclusion Criteria: * Patients with a diagnosis of Cystic Fibrosis * Contre indication of one of the tests * Exacerbation with hospitalization or outpatient clinic visit in the last 4 weeks. * Unability to obtain an informed consent * Pregnancy or Breast feeding
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bronchiectasis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chi Creteil
Créteil, 94000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simpler antibiotic course clear lung infections as well as a stronger one?
- A new twist on lung rehab: helping the helpers
- Gum treatment may lower lung flare-ups in bronchiectasis patients
- Can a daily pill cut dangerous lung Flare-Ups in bronchiectasis?
- Scientists track hidden threat of antibiotic resistance in lung patients
- Handheld breath test could spot lung disease early